Topics / Hormone Medicine

Men's Hormone Health

Testosterone therapy, estradiol in men, hematocrit, and male HRT controversies.

Dr. Rouzier's teaching

Webinars and commentary

Start here for Dr. Rouzier's perspective on Men's Hormone Health. Supporting published studies follow below.

Rouzier commentary

Testosterone therapy in appropriately selected hypogonadal men should be individualized with cardiovascular monitoring rather than categorically avoided.

Supporting evidence

Highest quality evidence

Published studies tagged to Men's Hormone Health, ordered by evidence strength. Inspect design and limitations before applying findings.

International journal of impotence research2022PMID 34999717

Testosterone replacement therapy and cardiovascular disease.

Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.

ReviewEvidence: ModerateRelevance: HighRouzier commentary
Testosterone & Cardiovascular Risk
OpenPublished November 2022Strength Moderate · Relevance High

Recent studies

2022Evidence: Moderate

Testosterone replacement therapy and cardiovascular disease.

International journal of impotence research

Contemporary evidence does not support the historical concern that testosterone replacement therapy broadly increases cardiovascular risk in appropriately selected men; benefits and risks depend on indication, formulation, monitoring, and baseline cardiovascular status.

Common clinical questions

Related topics